Literature DB >> 28780696

Evidence and decision algorithm for the withdrawal of antipsychotic treatment in the elderly with dementia and neuropsychiatric symptoms.

Marta Miarons1, Christopher Cabib2, Francisco Javier Barón3, Laia Rofes4.   

Abstract

PURPOSE: Antipsychotics (APs) are commonly used to manage neuropsychiatric symptoms (NPS) in elderly patients with dementia, even though several large studies have demonstrated an association between AP treatment and increased morbidity and mortality in people with dementia. The aim of this study is to review the scientific literature of the use of AP in the elderly with dementia and to propose an algorithm to assist in decision-making regarding the withdrawal of APs.
METHODS: A computerized literature search (MEDLINE: 1966 to December 2016, EMBASE: 1982 to December 2016) was used to locate relevant literature. Keywords in the search included terms from Medical Subject Headings (MESH) and EMBASE thesaurus (EMTREE). The following terms were used in the MESH database and EMTREE thesaurus: Aged, Antipsychotic Agents, Behavioral Symptoms and Dementia.
RESULTS: Earlier studies of APs used in elderly patients with dementia suggest that, in most elderly demented patients, APs can be withdrawn with no effect on behaviour. These patients are likely to benefit from the algorithm we propose to assist clinicians in the withdrawal of APs.
CONCLUSIONS: In this paper, we review the potential risks and benefits of discontinuing AP treatment in elderly demented patients with NPS and propose an algorithm to assist in decision-making regarding AP withdrawal.

Entities:  

Keywords:  Aged; Algorithm; Antipsychotic agents; Behavioural symptoms; Dementia; Drug-related side effects and adverse reactions

Mesh:

Substances:

Year:  2017        PMID: 28780696     DOI: 10.1007/s00228-017-2314-3

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  73 in total

Review 1.  The biological basis of behavioral symptoms in dementia.

Authors:  L Garand; K C Buckwalter; G R Hall
Journal:  Issues Ment Health Nurs       Date:  2000 Jan-Feb       Impact factor: 1.835

Review 2.  Consensus statement on improving the quality of mental health care in U.S. nursing homes: management of depression and behavioral symptoms associated with dementia.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2003-09       Impact factor: 5.562

3.  Withdrawal of neuroleptic medications from institutionalized dementia patients: results of a double-blind, baseline-treatment-controlled pilot study.

Authors:  S Bridges-Parlet; D Knopman; S Steffes
Journal:  J Geriatr Psychiatry Neurol       Date:  1997-07       Impact factor: 2.680

4.  Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.

Authors:  Clive Ballard; Marisa Margallo-Lana; Edmund Juszczak; Simon Douglas; Alan Swann; Alan Thomas; John O'Brien; Anna Everratt; Stuart Sadler; Clare Maddison; Lesley Lee; Carol Bannister; Ruth Elvish; Robin Jacoby
Journal:  BMJ       Date:  2005-02-18

5.  The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia.

Authors:  Kate de Medeiros; P Robert; S Gauthier; F Stella; A Politis; J Leoutsakos; F Taragano; J Kremer; A Brugnolo; A P Porsteinsson; Y E Geda; H Brodaty; G Gazdag; J Cummings; C Lyketsos
Journal:  Int Psychogeriatr       Date:  2010-07-01       Impact factor: 3.878

6.  Differential pharmacology of atypical antipsychotics: clinical implications.

Authors:  Prakash S Masand
Journal:  Am J Health Syst Pharm       Date:  2007-01-15       Impact factor: 2.637

Review 7.  Thioridazine for dementia.

Authors:  V Kirchner; C A Kelly; R J Harvey
Journal:  Cochrane Database Syst Rev       Date:  2001

8.  Newly diagnosed dementia and increased risk of hemorrhagic stroke: A nationwide population-based study.

Authors:  Hao-Kuang Wang; Kuen-Jer Tsai; Chih-Yuan Huang; Liang-Chao Wang; Kang Lu; Han-Jung Chen; Chi-Wei Lin; Yi-Jer Lee; Pei-Hsuan Fang; Li-Ching Chang; Ying-Chun Li
Journal:  Curr Alzheimer Res       Date:  2014-03       Impact factor: 3.498

9.  Variation in nursing home antipsychotic prescribing rates.

Authors:  Paula A Rochon; Therese A Stukel; Susan E Bronskill; Tara Gomes; Kathy Sykora; Walter P Wodchis; Michael Hillmer; Alexander Kopp; Jerry H Gurwitz; Geoffrey M Anderson
Journal:  Arch Intern Med       Date:  2007-04-09

Review 10.  Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: a systematic review.

Authors:  Jo Thompson Coon; Rebecca Abbott; Morwenna Rogers; Rebecca Whear; Stephen Pearson; Iain Lang; Nick Cartmell; Ken Stein
Journal:  J Am Med Dir Assoc       Date:  2014-08-08       Impact factor: 4.669

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.